Identifying patients with suspected gastro-oesophageal cancer in primary care: Derivation and validation of an algorithm

British Journal of General Practice

Volumn 61, Issue 592, 2011, Pages

  Hippisley Cox, Julia ^a   Coupland, Carol ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Diagnosis; Gastrointestinal cancer; Primary care; Qresearch; Risk prediction; Symptoms

Indexed keywords

ABDOMINAL PAIN; ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANOREXIA; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER RISK; DYSPHAGIA; ESOPHAGUS CANCER; FAMILY HISTORY; FATIGUE; FEMALE; GENERAL PRACTICE; HEMATEMESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PRIMARY MEDICAL CARE; SMOKING; STOMACH CANCER; WEIGHT REDUCTION;

ABDOMINAL PAIN; ADULT; AGED; ALGORITHMS; APPETITE; DEGLUTITION DISORDERS; EARLY DETECTION OF CANCER; ENGLAND; ESOPHAGEAL NEOPLASMS; FEMALE; GENERAL PRACTICE; HEMATEMESIS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOM ALLOCATION; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS; WALES; WEIGHT LOSS;

EID: 83355174133     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp11X606609     Document Type: Article

References (31)

1. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18(3): 581-592. (Pubitemid 46359643)
2. Thomson CS, Forman D. Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results? Br J Cancer 2009; 101(Suppl 2): S102-109.
3. Richards MA. The National Awareness and Early Diagnosis Initiative in England: assembling the evidence. Br J Cancer 2009; 101(Suppl 2): S1-4.
4. Department of Health. The Cancer Reform Strategy. London: Department of Health, 2007.
5. Vakil N, Moayyedi P, Fennerty MB, Talley NJ. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology 2006; 131(2): 390-401; quiz 659-660.
6. Varadarajulu S, Eloubeidi MA, Patel RS, et al. The yield and the predictors of esophageal pathology when upper endoscopy is used for the initial evaluation of dysphagia. Gastrointest Endosc 2005; 61(7): 804-808. (Pubitemid 40779408)
7. Meineche-Schmidt V, Jorgensen T. 'Alarm symptoms' in patients with dyspepsia: a three-year prospective study from general practice. Scand J Gastroenterol 2002; 37(9): 999-1007.
8. Jones R, Latinovic R, Charlton J, Gulliford MC. Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ 2007; 334(7602): 1040.
9. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008; 336(7659): 1475-1482. (Pubitemid 351977019)
10. Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ 2009; 339: b4229.
11. Hippisley-Cox J, Coupland C, Robson J, et al. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 2009; 338: b880.
12. Hippisley-Cox J, Coupland C. Predicting the risk of chronic kidney disease in men and women in england and Wales: prospective derivation and external validation of the QKidney® Scores. BMC Fam Pract 2010; 11(1): 49.
13. Hippisley-Cox J, Coupland C. Identifying patients with suspected lung cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract 2011; DOI: 10.3399/bjgp11X606627.
14. Jones R, Charlton J, Latinovic R, Gulliford MC. Alarm symptoms and identification of non-cancer diagnoses in primary care: cohort study. BMJ 2009; 339: b3094.
15. Collins GS, Altman DG. External validation of the QDScore for predicting the 10-year risk of developing Type 2 diabetes. Diabet Med 2011; 28(5): 599-607.
16. Collins GS, Altman DG. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. BMJ 2010; 340: c2442.
17. Collins GS, Altman DG. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. BMJ 2009; 339: b2584.
18. Schafer J, Graham J. Missing data: our view of the state of the art. Psychol Methods 2002; 7: 147-177.
19. Group TAM. Academic medicine: problems and solutions. BMJ 1989; 298: 573-579.
20. Steyerberg EW, van Veen M. Imputation is beneficial for handling missing data in predictive models. J Epidemiol Community Health 2007; 60(9): 979. (Pubitemid 47208539)
21. Moons KGM, Donders RART, Stijnen T, Harrell FJ. Using the outcome for imputation of missing predictor values was preferred. J Epidemiol Community Health 2006; 59(10): 1092.
22. Rubin DB. Multiple imputation for non-response in surveys. New York: John Wiley, 1987.
23. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999; 28(5): 964-974. (Pubitemid 29525041)
24. Hosmer D, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons Inc., 1989.
25. Royston P. Explained variation for survival models. Stata J 2006; 6: 1-14.
26. Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Stat Med 2004; 23(5): 723-748. (Pubitemid 38279510)
27. Hippisley-Cox J, Coupland C. Predicting the risk of osteoporotic fracture in England and Wales: prosepctive derivation and validation of the QFractureScore. BMJ 2009; 339: b4229.
28. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991; 302(6779): 766-768.
29. Herrett E, Thomas SL, Schoonen WM, et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010; 69(1): 4-14.
30. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract 2010; 60(572): e128-136.
31. Jick H, Jick S, Derby LE, et al. Calcium-channel blockers and risk of cancer. Lancet 1997; 349(9051): 525-528. (Pubitemid 27092790)